Nanotechnology and Antivirus Nanomaterials for Combating COVID-19: Strategies against SARS-CoV-2 Variants in the Post-pandemic Era explores the state-of-the-art and advancements in nanotechnology to fight SARS-CoV-2 and its variants. Providing a comprehensive overview, the chapters cover the molecular mechanisms of viral infection and advanced tools for diagnosis, prevention, treatments, drug development, and vaccine creation, offering valuable insights into managing COVID-19. The book also includes discussions on potential challenges and future research directions. This book is a valuable…mehr
Nanotechnology and Antivirus Nanomaterials for Combating COVID-19: Strategies against SARS-CoV-2 Variants in the Post-pandemic Era explores the state-of-the-art and advancements in nanotechnology to fight SARS-CoV-2 and its variants. Providing a comprehensive overview, the chapters cover the molecular mechanisms of viral infection and advanced tools for diagnosis, prevention, treatments, drug development, and vaccine creation, offering valuable insights into managing COVID-19. The book also includes discussions on potential challenges and future research directions. This book is a valuable resource for researchers, scientists, and professionals seeking a deeper understanding of nanotechnology's applications for preventing, diagnosing, and managing COVID-19.
1. A comprehensive review of epidemiology, virology, and prevention for COVID 19 and its variants 2. Coronavirus Disease 2019 and the SARS CoV 2 variants: Virological perspectives 3. Introduction to antiviral nanomaterials: Mechanisms and applications 4. An overview of antiviral nanomedicine: Types, structures and functions 5. Nanotechnology based strategies for combating SARS CoV 2 variants 6. Nanotechnology for diagnosis of COVID 19: Current achievements and future directions 7. Nanomaterial based therapeutic drugs for SARS CoV 2 variants: Recent finding, limitations, and prospects 8. The development of lipid nanoparticle technology for the management of COVID 19 9. Nanotechnology for the prevention of SARS CoV 2 infection 10. Nanotechnology assisted therapeutic antibodies against SARS CoV 2 variants: Current findings and future perspectives 11. COVID 19 drug delivery: Current achievements and the impact of nanocarriers 12. Nanotechnology based drug delivery for combating SARS CoV 2 variants 13. An overview of COVID 19 vaccine development: Highlighting the role of nanotechnology 14. Nanotechnology based vaccine development for COVID 19 15. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID 19 management 16. Anti SARS CoV 2 nanoparticles: Mechanisms and applications 17. Engineered nanoparticles for the management of COVID 19 and new variants of SARS CoV 2 18. Nature’s arsenal: Combatting SARS CoV 2 variants with phytocompound nanoparticles 19. Emerging nanomaterials for COVID 19 therapeutics 20. Metallic nanoparticles based strategies for COVID 19 management in the post pandemic era 21.. Nanotechnological Approaches for COVID 19 Management: Highlighting the Impact on SARS Co V 2 Variants 22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID 19 and Other Infectious Diseases
1. A comprehensive review of epidemiology, virology, and prevention for COVID 19 and its variants 2. Coronavirus Disease 2019 and the SARS CoV 2 variants: Virological perspectives 3. Introduction to antiviral nanomaterials: Mechanisms and applications 4. An overview of antiviral nanomedicine: Types, structures and functions 5. Nanotechnology based strategies for combating SARS CoV 2 variants 6. Nanotechnology for diagnosis of COVID 19: Current achievements and future directions 7. Nanomaterial based therapeutic drugs for SARS CoV 2 variants: Recent finding, limitations, and prospects 8. The development of lipid nanoparticle technology for the management of COVID 19 9. Nanotechnology for the prevention of SARS CoV 2 infection 10. Nanotechnology assisted therapeutic antibodies against SARS CoV 2 variants: Current findings and future perspectives 11. COVID 19 drug delivery: Current achievements and the impact of nanocarriers 12. Nanotechnology based drug delivery for combating SARS CoV 2 variants 13. An overview of COVID 19 vaccine development: Highlighting the role of nanotechnology 14. Nanotechnology based vaccine development for COVID 19 15. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID 19 management 16. Anti SARS CoV 2 nanoparticles: Mechanisms and applications 17. Engineered nanoparticles for the management of COVID 19 and new variants of SARS CoV 2 18. Nature’s arsenal: Combatting SARS CoV 2 variants with phytocompound nanoparticles 19. Emerging nanomaterials for COVID 19 therapeutics 20. Metallic nanoparticles based strategies for COVID 19 management in the post pandemic era 21.. Nanotechnological Approaches for COVID 19 Management: Highlighting the Impact on SARS Co V 2 Variants 22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID 19 and Other Infectious Diseases
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
